‘New lead’ in hunt for better schizophrenia drugs
One per cent of the U.S. population is affected with schizophrenia. Symptoms can be positive or negative. Positive symptoms include hallucinations and delusions while negative symptoms include lack of motivation and an inability to experience pleasure.
Presently, antipsychotics are the go-to medications to manage the positive symptoms. However, researchers have discovered that Mu-opioid receptors (MORs) can be targeted for negative symptoms. Schizophrenics were found to have considerably lower amount of MORs in their brains when compared to the control groups.
Even though data are still preliminary, they provide a basis for further research on MORs which might hold the potential to provide more improved treatments for schizophrenia.